Über das Unternehmen
- Firmenname (rechtlich): Fidia Farmaceutici Spa
- Registrierungsland: Italy
- Adresse: Via Ponte della Fabbrica 3/A - 35031 Abano Terme (PD) • Veneto
- Anzahl der Mitarbeiter: 1000 - 4999
- Gründungsjahr: 1946
Beschreibung:
Fidia farmaceutici S.p.A. a fully integrated Italian healthcare company, part of the P&R Group, with R&D, manufacturing, marketing and sales capabilities, operates worldwide to develop and market innovative products (pharmaceuticals, medical devices and dietary supplements), mainly based on sodium hyaluronate (HY) and its derivatives. Major business areas include treatment of joint disorders, Advanced Wound Care and Dermo-aesthetics. Fidia is a world leader in HY production, using proprietary and validated extraction and fermentation processes. The Company's manufacturing operation is FDA-inspected and approved.
Geschäftsaktivitäten
Pharmazeutische Wirkstoffe (API)
API-HerstellerHersteller
Medizinprodukte & Ausrüstung
Medizinprodukthersteller
Lohnverpackungsdienstleistungen
HerstellerVertriebspartner
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
HerstellerVertriebspartner
Original-Wirkstoffe
HerstellerVertriebspartner
Fertigarzneiformen
VertriebspartnerMarketing Authorization HolderHersteller
Hauptprodukte/-dienstleistungen
- Fertigarzneiformen: Replasyn, Sodium hyaluronate MW 500-730 kDa, Itami patch, Diclofenac sodium salt 140 mg
- Kosmetika und Körperpflege: Hair and skin care products
- Naturextrakte & Pflanzliche Rohstoffe: CartiJoint Forte
- Pharmazeutische Chemikalien: Hyaluronic acid based medicines
- Biopharmazeutische Produkte: Hy-Tissue autologous biological therapy line
- Lohnverpackungsdienstleistungen: Hyalo4 Foam family, Hyalo4 High Gelling Fibre, Hyalo4 Silver spray 50/125 ML • HA 0,25% (200 kDa) • Ag 1% (Metallic Silver) • Vitamin E
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): Hyalo4 Hydro, Hyalo Gyn/ Hyalofemme line HYDEAL-D (prolonged-release hyaluronic acid derivative) 0.2%, Hydeal Cyst Hyaluronic acid sodium salt 1.8% + HYDEAL-D® 0.2% (prolonged-release hyaluronic acid derivative), Fidial Plus Sodium hyaluronate 1.8%, OPHTHALMOLOGY line (dry eye, hygene, keratoconus, corneal edema, dietary supplements)
Unsere Produkte & Dienstleistungen
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Natural Extracts & Herbal Ingredients
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
CE
FDA
GMP
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen